Target intelligence / Profile preview

Small nuclear ribonucleoprotein-associated protein N (SNRPN)

Target
SNRPN
Molecular classification
Other (snRNP component protein), RNA-binding protein
01

Overview

Small nuclear ribonucleoprotein-associated protein N (SNRPN) is a human protein encoded by the SNRPN gene and forms part of the small nuclear ribonucleoprotein (snRNP) complexes, specifically the Sm-class of snRNPs[1][5]. These complexes play a critical role in nuclear RNA processing, including pre-mRNA splicing and potentially tissue-specific alternative splicing events, acting within the spliceosome to remove introns from precursor mRNA[1][2][6]. SNRPN is involved in imprinting and gene regulation, particularly within the Prader-Willi syndrome critical region on chromosome 15; defects in this gene, such as abnormal imprinting, are linked to Prader-Willi syndrome[1][5]. SNRPN is not a conventional receptor, enzyme, or drug target, and there are no known drugs that directly interact with it or target it for therapeutic intervention. SNRPN methylation status is used clinically as a biomarker for diagnosing uniparental disomy in chromosome 15-related disorders[1].

Other names
Small nuclear ribonucleoprotein polypeptide NSNRPNSmN protein
02

Biological functions

Pre-mRNA processingAlternative splicingPost-transcriptional gene regulation
03

Disease associations

Prader-Willi syndromeGenetic imprinting disorders
04

Biomarkers

SNRPN methylation (for detection of uniparental disomy of chromosome 15)

Beyond the preview

Go deeper on Small nuclear ribonucleoprotein-associated protein N (SNRPN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nuclear ribonucleoprotein-associated protein N (SNRPN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call